Rezultati
eNauka >
Rezultati >
Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo Or Adalimumab: Results from a Phase 3 Trial
Naziv  : | Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo Or Adalimumab: Results from a Phase 3 Trial | Autori: | Gossec, Laure; Damjanov, Nemanja S; Tsuji, Shigeyoshi; Lertratanakul, Apinya; Lippe, Ralph; Patel, Janki; Zueger, Patrick; De, Vlam K | Godina: | 2022 | Publikacija: | ANNALS OF THE RHEUMATIC DISEASES | ISSN: | 0003-4967 Annals of the Rheumatic Diseases Pretraži identifikator |
Tip rezultata: | Konferencijski rad | Kolacija: | vol. 81 br. Suppl 1 str. 1569-1570 | DOI: | 10.1136/annrheumdis-2022-eular.1371 | WoS-ID: | 000850279006285 | URI: | https://enauka.gov.rs/handle/123456789/819043 | Projekat: | AbbVie Inc. | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.